BR0208440A - Derivados de pirimidina-2,4,6-triona, processos para sua produção e agentes farmacêuticos contendo esses compostos - Google Patents

Derivados de pirimidina-2,4,6-triona, processos para sua produção e agentes farmacêuticos contendo esses compostos

Info

Publication number
BR0208440A
BR0208440A BR0208440-6A BR0208440A BR0208440A BR 0208440 A BR0208440 A BR 0208440A BR 0208440 A BR0208440 A BR 0208440A BR 0208440 A BR0208440 A BR 0208440A
Authority
BR
Brazil
Prior art keywords
compounds
pyrimidine
processes
production
pharmaceutical agents
Prior art date
Application number
BR0208440-6A
Other languages
English (en)
Inventor
Dagmar Geppert
Frank Grams
Hans-Willi Krell
Herbert Leinert
Ernesto Menta
Gerd Zimmermann
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of BR0208440A publication Critical patent/BR0208440A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60—Three or more oxygen or sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60—Three or more oxygen or sulfur atoms
    • C07D239/62—Barbituric acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

"DERIVADOS DE PIRIMIDINA-2,4,6-TRIONA, PROCESSOS PARA SUA PRODUçãO E AGENTES FARMACêUTICOS CONTENDO ESSES COMPOSTOS". A presente invenção refere-se a compostos de fórmula I em que R1 representa um resíduo substituído ou não-substituído fenila, fenóxi, feniltio, fenilsulfenila, fenilsulfonila, fenilamino ou fenilmetila, R2 representa hidrogênio, R3 representa hidrogênio ou alquil, R4 representa alquila, arila, aralquila, heterila ou acila, e R2 e R3 e R4 formam um anel piperazina o qual pode ser substituído, com atividade inibitória de metaloproteinase.
BR0208440-6A 2001-03-30 2002-03-26 Derivados de pirimidina-2,4,6-triona, processos para sua produção e agentes farmacêuticos contendo esses compostos BR0208440A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01107714 2001-03-30
PCT/EP2002/003366 WO2002079170A2 (en) 2001-03-30 2002-03-26 Pyrimidine-2,4,6-trione derivatives, processes for their production and pharmaceutical agents containing them

Publications (1)

Publication Number Publication Date
BR0208440A true BR0208440A (pt) 2004-03-30

Family

ID=8176973

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0208440-6A BR0208440A (pt) 2001-03-30 2002-03-26 Derivados de pirimidina-2,4,6-triona, processos para sua produção e agentes farmacêuticos contendo esses compostos

Country Status (15)

Country Link
US (1) US6716845B2 (pt)
EP (1) EP1383746A2 (pt)
JP (1) JP2004533425A (pt)
KR (1) KR20030086335A (pt)
CN (1) CN1273454C (pt)
AR (1) AR035800A1 (pt)
AU (1) AU2002302470C1 (pt)
BR (1) BR0208440A (pt)
CA (1) CA2442354A1 (pt)
MX (1) MXPA03008588A (pt)
PA (1) PA8542001A1 (pt)
PE (1) PE20021101A1 (pt)
UY (1) UY27239A1 (pt)
WO (1) WO2002079170A2 (pt)
ZA (1) ZA200306615B (pt)

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4595700A (en) 1984-12-21 1986-06-17 G. D. Searle & Co. Thiol based collagenase inhibitors
GB8726714D0 (en) 1987-11-14 1987-12-16 Beecham Group Plc Compounds
GB8827305D0 (en) 1988-11-23 1988-12-29 British Bio Technology Compounds
US5239078A (en) 1990-11-21 1993-08-24 Glycomed Incorporated Matrix metalloprotease inhibitors
DK0489579T3 (da) 1990-12-03 1995-06-12 Celltech Therapeutics Ltd Peptidylderivater
CA2058797A1 (en) 1991-02-01 1992-08-02 Michael John Broadhurst Amino acid derivatives
US5789434A (en) 1994-11-15 1998-08-04 Bayer Corporation Derivatives of substituted 4-biarylbutyric acid as matrix metalloprotease inhibitors
AU725831C (en) 1995-12-08 2002-10-17 Agouron Pharmaceuticals, Inc. Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses, and methods and intermediates useful for their preparation
DE19548624A1 (de) 1995-12-23 1997-06-26 Boehringer Mannheim Gmbh Neue Barbitursäure-Derivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
DE19726427A1 (de) * 1997-06-23 1998-12-24 Boehringer Mannheim Gmbh Pyrimidin-2,4,6-trion-Derivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
US6350786B1 (en) 1998-09-22 2002-02-26 Hoffmann-La Roche Inc. Stable complexes of poorly soluble compounds in ionic polymers
PE20010659A1 (es) 1999-10-01 2001-06-20 Hoffmann La Roche Derivados de las pirimidin-2,4,6-trionas como inhibidores de metaloproteasas

Also Published As

Publication number Publication date
AR035800A1 (es) 2004-07-14
CN1273454C (zh) 2006-09-06
JP2004533425A (ja) 2004-11-04
CA2442354A1 (en) 2002-10-10
US20020187991A1 (en) 2002-12-12
UY27239A1 (es) 2002-09-30
AU2002302470C1 (en) 2008-07-24
CN1553901A (zh) 2004-12-08
WO2002079170A3 (en) 2003-11-27
AU2002302470B2 (en) 2008-02-14
ZA200306615B (en) 2004-11-25
US6716845B2 (en) 2004-04-06
KR20030086335A (ko) 2003-11-07
MXPA03008588A (es) 2003-12-08
PE20021101A1 (es) 2003-02-13
WO2002079170A2 (en) 2002-10-10
PA8542001A1 (es) 2002-10-28
EP1383746A2 (en) 2004-01-28

Similar Documents

Publication Publication Date Title
ES2182234T3 (es) Inhibidores de metaloproteasa.
BRPI0408347A (pt) derivados de pirimidina
NO995846D0 (no) Oksazolidinon-antibakterielle midler med en tiokarbonylfunksjonalitet
MY136141A (en) Novel hydantoin derivatives and pharmaceutical compositions useful as metalloproteinase inhibitors
BRPI0112986B8 (pt) compostos azabicíclicos, processo para a sua preparação, bem como composições farmacêuticas compreendendo os ditos compostos
DK168488A (da) Quinazolinderivater, fremgangsmaade til fremstilling deraf samt farmaceutiske midler indeholdende disse
AR042273A1 (es) Derivados de pirazol, procedimiento para prepararlos y las composiciones farmaceuticas que los contienen
ATE260275T1 (de) Substituierte thien-3-yl- sulfonylamino(thio)carbonyl-triazolin(thi)one
UY26057A1 (es) Amidas de aminoacidos modificadas, medicamentos que contienen estos compuestos y procedimiento para su preparacion
BR9802804A (pt) Compostos benzimidazol, benzoxazol e benzotiazol, processo para sua preparação e composições farmacéuticas contendo os mesmos.
DE69808619T2 (de) Prostaglandin-pharmazeutische-zusammensetzungen
BR9909739A (pt) Benzotiadiazóis e derivados
BRPI0418255A (pt) derivados de piperazina e piperidina n-substituìdos
BR0213990A (pt) Derivados de piperazina tendo atividade antagonìstica de sst1
AR027112A1 (es) Derivados de piperazina sustituidos, su preparacion, su empleo como medicamentos
HUP0202832A2 (hu) Új pirimidin-2,4,6-trion-származékok, alkalmazásuk, valamint az e vegyületeket tartalmazó gyógyászati készítmények
BR0309668A (pt) Imidazolinilmetil aralquilsulfonamidas
BR0208440A (pt) Derivados de pirimidina-2,4,6-triona, processos para sua produção e agentes farmacêuticos contendo esses compostos
ES2124413T3 (es) Derivados de piridazinona con actividad farmaceutica.
BR0307424A (pt) Compostos heterocìclicos com atividade inibidora de elastase e seus intermediários
BRPI0415885A (pt) ácidos piperidinil-e piperazinil-sulfonilmetilidroxámicos e sua utilização como inibidores de protease
AR027349A1 (es) Derivados de amidas heterociclicas
NO20000423D0 (no) Tiazolobenzoheterocykler, deres fremstilling samt medikamenter inneholdende forbindelsene
TNSN98119A1 (fr) Nouveaux derives de 4-hydroxy-2h-1-(thio)pyran-2-ones, leurs preparations et leurs utilisations comme rodonticides.
ATE171622T1 (de) Antiallergische zusammensetzung enthaltend eine phosphorsäurediester-verbindung

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 9A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2137 DE 20/12/2011.